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Abstract
Background: Community-acquired methicillin-resistant Staphylococcus aureus have become a major problem in Australia.
These strains have now been isolated throughout Australia including remote Indigenous communities that have had
minimal exposure to healthcare facilities. Some of these strains, belonging to sequence types ST75 and ST883, have
previously been reported to harbour highly divergent alleles of the housekeeping genes used in multilocus sequence
typing.
Methodology/Principal Findings: ST75-MRSA-IV and ST883-MRSA-IV isolates were characterised in detail. Morphological
features as well as 16S sequences were identical to other S. aureus strains. Although a partial rnpB gene sequence was not
identical to previously known S. aureus sequences, it was found to be more closely related to S. aureus than to other
staphylococci. Isolates also were screened using diagnostic DNA microarrays. These isolates yielded hybridisation results
atypical for S. aureus. Primer directed amplification assays failed to detect species markers (femA, katA, sbi, spa). However,
arbitrarily primed amplification indicated the presence of unknown alleles of these genes. Isolates could not be assigned to
capsule types 1, 5 or 8. The allelic group of the accessory gene regulator (agr) locus was not determinable. Sequencing of a
region of agrB, agrC and agrD (approximately 2,100 bp) revealed a divergent sequence. However, this sequence is more
related to S. aureus agr alleles I and IV than to agr sequences from other Staphylococcus species. The predicted auto-
inducing peptide (AIP) sequence of ST75 was identical to that of agr group I, while the predicted AIP sequence of ST883 was
identical to agr group IV.
Conclusions/Significance: The genetic properties of ST75/ST883-MRSA may be due to a series of evolutionary events in
ancient insulated S. aureus strains including a convergent evolution leading to agr group I- or IV-like AIP sequences and a
recent acquisition of SCCmec IV elements.
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Introduction
A variety of community-acquired methicillin-resistant S. aureus
(ca-MRSA) strains with divergent genetic backgrounds have
emerged globally. In Australia some of these strains have been
isolated from Indigenous people living in remote communities who
have had minimal previous exposure to healthcare facilities. One
of these strains, ST75-MRSA-IV, is a PVL-negative ca-MRSA
frequently isolated from skin and soft tissue infections in people
living in the northern regions of Australia [1]. Recently it has been
demonstrated that the multilocus sequence typing (MLST) genes
in ST75 differ from other S. aureus. Using array hybridisation, the
accessory gene regulator (agr) genes in ST75-MRSA-IV and in a
related ST883-MRSA-IV strain could not be detected [2].
Although no phenotypic differences to other S. aureus were
observed, it has been proposed to classify these strains as a new
subspecies of S. aureus [3].
As a toxin signatory pathway, the agr locus genes encode AgrA,
AgrB, AgrC, and AgrD that constitute a virulence regulating
quorum-sensing system [4-6]. This system responds to the
extracellular concentration of a secreted auto-inducing peptide
(AIP) derived from AgrD. AgrB is a putative processing enzyme,
and AgrC serves as receptor for AIP. Quorum sensing via AIP
regulates the expression of RNAIII derived from the hld gene.
RNAIII up-regulates the production of secreted toxins, but down-
regulates genes encoding surface proteins. The central segment of
the agr locus (the C-terminal two-thirds of AgrB, AgrD, and the N-
terminal half of AgrC) shows a striking interstrain variation.
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S. aureus strains into these agr groups is based on their
experimentally proven ability to inhibit or stimulate expression
of virulence-related genes. The agent mediating this modulation of
virulence gene expression is AIP. Its sequence is different in each
agr group. AIP stimulates expression of virulence genes in its own
agr group, but represses these genes in strains of a different agr
group, resulting in bacterial interference [8]. It has previously been
proposed that the four different alleles of the agr cluster reflect an
ancient division in S. aureus evolution [7]. However, strains
belonging to related clonal complexes based on MLST have been
shown to have different agr groups. Furthermore, highly divergent
clonal complexes have been shown to harbour identical agr alleles
[2]. Consequently, the concept of a straightforward division of S.
aureus into four agr groups attaining some kind of subspecies status
is not valid. Proposals for a phylogenetic tree of S. aureus, made to
explain the discrepancies between overall genetic background and
agr group affiliations, assume multiple steps of diversification and
recombination [9;10].
As ST75-MRSA-IV may be a new subspecies of S aureus, the
aim of this study was to characterise several of these isolates using
phenotypic and genotypic methods. For genotypic characterisa-
tion, hybridisation patterns on DNA arrays were analysed. Genes
encoding the 16S rRNA and the RNA subunit of RNase P (rnpB)
genes were sequenced, as these genes have previously been used to
infer taxonomy and phylogeny (see, e.g., [11–14]). As agr regulation
is a vital pathway in S. aureus, the failure to detect known alleles of
agr locus genes in ST75-MRSA-IV and ST883-MRSA-IV suggests
the presence of new alleles of these genes. Consequently, a
characterisation of the agr locus of these isolates was performed in
this study.
Results
Phenotypic characterisation
Morphologically on Columbia blood agar, isolates formed
yellow-greyish colonies with beta-haemolysis. The clumping factor
test was positive. Standard biochemistry was in accordance with
the Vitek 2 S. aureus profile (Supplemental File S1). The urease test
was negative for ST75-MRSA-IV, but positive for ST883-MRSA-
IV. ST75-MRSA-IV and ST883-MRSA-IV isolates were also
identified as S. aureus using MALDI-TOF.
Array hybridisation
Detailed hybridisation results are provided in Supplemental File
S2.
ST75-MRSA-IV and ST883-MRSA-IV provided hybridisation
patterns distinct from other S. aureus strains. Some of the
characteristic S. aureus markers including coa, spa, katA, femA or
sbi did not yield hybridisation signals in both amplification
protocols, or were detectable only when using the sequence-
independent random-primer amplification (Supplemental File S2).
This can be attributed to the present of distinct sequences which
are sufficiently divergent to prevent their detection. Indeed, a
previously published ST75 coa sequence (GenBank AB436988,
strain JCSC1469, [15]) shows mismatches affecting primer and
probe binding sites. The spa gene is known to be present in both
strains, as a spa types have previously been reported ([16], 259-31-
17-17-17-23-17-17-23-17-22 for ST75-MRSA-IV and 259-23-23-
17-17-17-23-23-23-17-16 for ST883-MRSA-IV). For katA, femA
and sbi genes, confirmatory PCRs were designed (Table 1). The
ST75-MRSA-IV isolate 03-17848 yielded products of the
expected size for these PCRs. The ST883-MRSA-IV isolate 06-
Table 1. Primers used for amplification and sequencing of genes in ST75-MRSA-IV and ST883-MRSA-IV.
PCR Target localisation
Forward Primer sequences
(59-…-39)
Reverse Primer sequences
(59-…-39)
Length
(bp) Tann
Sa16S 16S rRNA TTTTATGGAGAGTTTGATCC AGAAAGGAGGTGATCCAG 1,555 51uC
Sa16S-1 Sequencing primer for
Sa16S PCR product
GTCCGCCGCTAACATCAG - - 55,7uC
Sa16S-2 Sequencing primer for
Sa16S PCR product
ATAGATGGATCCGCGCTG - - 54,1uC
Sa16S-3 Sequencing primer for
Sa16S PCR product
ACAACCATGCACCACCTG - - 55,2uC
Sa16S-4 Sequencing primer for
Sa16S PCR product
AATCGCTAGTAATCGTAG - - 45,7uC
rnpB-fw-01/rnpB-rv-02 rnpB AGTTTAACTGTCTTACTAATAATGACT ACAAGGCAGTGTCATTATATCA 528 60uC
agrC_uni_fw/agrA_uni_rv agrC to agrA CATGATTATGTCAATATCTT TGTTTTCTCTTTGTTTTG 650 33uC
agrB_uni_fw/agrC_uni_rv Upstream of agrB to agrC AAAGATTGTACTAAATCGT GTCGTTAAGATATTGACA 1500 33uC
pr_agr01_fw/pr_agr02_rv agrB to agrC ATTTTCTTTATTAAGGAGGA GAATACCATTTGATTTTGA 435 38uC
pr_agr03_fw/pr_agr04_rv agrC TCAAAATCAAATGGTATTC TTTTATTGAAATAGTCACG 585 38uC
pr_agr11-fw/pr_agr12-rv agrB to agrD GGTGTTATGTAGAGAGTATTATATTGT AACATTAATATCATTTGAGTTAATACGAA 530 52uC
pr_agr13-fw/pr_agr14-rv agrC CCAAAAGAATTAACTCAATTACACG AGTAAGCAGTAAGATGGTCGA 530 52uC
pr_agr15-fw/pr_agr16-rv agrC GAAGCAAAAGTAATAAGGCAGT TCAAGAATAATACCAATACTGCG 530 52uC
katA_outframe katA, out frame CTGATTTTTTAATCATCTTGAGCATG GTTACGTTTACGCGCACG 1725 55uC
katA_inframe katA, in frame CGAGAAAATAGTATGACAGCAGG CATAAACTGCTCAACTACGCAATATAG 1505 55uC
femA_02/04_outframe femA, out frame AACGAGAGACAAATAGGAGTAATG CAAATTCGGTAACAGTTAACTCTG 1345 55uC
sbi_inframe sbi, in frame CAGCAACAATTACTTTAGCTACAATG CTAGAGAAGATATTTTTGATTGATTATTTCC 1405 55uC
doi:10.1371/journal.pone.0014025.t001
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did not amplify in the katA (out frame) PCR.
Other species-specific genes such as gapA, nuc, setC, hld, and some
of the genes encoding microbial surface components recognising
adhesive matrix molecules (MSCRAMM), such as bbp, clfA/B, eno,
fnbA/B and sdrC/D and the biofilm-associated gene icaA were
detected. Other MSCRAMM genes, cna, ebpS, fib, map and vwb,a s
well as biofilm-associated genes icaC/D and bap were not detected.
The sasG gene was detected in ST75, but not in ST883. Isolates
did not yield signals with probes for capH, capI, capJ and capK genes
corresponding to the capsule types 1, 5 or 8, in either the primer–
directed, or the random amplification protocols.
The affiliation to agr groups could not be determined as no
signals were obtained with primers and probes derived from all
previously described S. aureus agr locus sequences. Other regulatory
genes, sarA, saeR, saeS, vraS, were detectable, while vraR yielded
weak (in ST75-MRSA-IV) or no signals (in ST883-MRSA-IV).
ST75-MRSA-IV carried the egc enterotoxin gene cluster locus
including seg, sei, sem, seo and seu. Another gene from this cluster,
sen, was only detectable by random amplification. The ST75-
MRSA-IV isolates differed in the presence of the enterotoxin B
gene seb. Eleven isolates yielded either no signals, or in the random
amplification protocol only, while seven isolates were positive in
the primer-directed amplification. Two isolates from the former
group failed to produce enterotoxin B, while two isolates from the
latter group were positive for toxin production (Supplemental File
S3). Enterotoxin genes were not detected in ST883-MRSA-IV,
and this strain did not produce enterotoxin B. This isolate also
differed from ST75 with regard to some other markers such as ssl/
set and hysA alleles (Supplemental File S2). The gamma haemolysin
locus (hlgA, lukF/S-hlg), PVL genes (lukF/S-PV) and the leukocidin
homologues lukD/E and ‘‘lukX/Y’’ (NC_002951; SACOL2004
and 2005) were not detected.
All isolates carried SCCmec IV elements. ST75-MRSA-IV
isolates harboured blaZ, blaR and blaI. Other resistance determi-
nants, msrA, qacA and qacC, were found in some ST75-MRSA-IV
isolates. The ST883-MRSA-IV isolate lacked blaZ/R/I, but
harboured ermC.
Sequencing
The 16S rRNA gene sequences of isolates 03-17848 (ST75-
MRSA-IV, HQ260331) and 06-16607 (ST883-MRSA-IV, Gen-
Bank HQ260332) were identical to other S. aureus strains. The rnpB
gene sequences of these two strains (GenBank HQ260329 and
HQ260330, respectively) were identical to each other. With a
97.5% sequence homology, these two strains were more related to
S. aureus than to other Staphylococcus species (with sequence
homologies of 87%; S. saprophyticus ATCC 15305, AP008934.1
to 90%; S. lugdunensis HKU09-01, CP001837.1; Figure 1).
Approximately 2,045 base pairs of agrB, agrD and agrC of the
ST75-MRSA-IV isolate 03-17848 were sequenced (GenBank
FJ154839). Sequences revealed differences to known agr S. aureus
sequences. Although they were not completely identical, agrB, agrD
and agrC sequences from the ST883-MRSA-IV isolate 06-16607
(GenBank HQ260328) resembled ST75-MRSA-IV. BLAST
yielded an identity of 92% with query coverage of 100%. Both
sequences are more closely related to S. aureus agr alleles than to
other staphylococcal agr sequences (Figure 2). Among the S. aureus
Figure 1. Phylogenetic network reconstruction based on DNA sequences of staphylococcal rnpB genes.
doi:10.1371/journal.pone.0014025.g001
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to agr groups II or III. A protein sequence alignment (Supple-
mental File S4) revealed that the putative AIP sequence of ST75
was identical to agr group I, and that the predicted AIP sequence
of ST883 was identical to agr group IV.
Discussion
Australian ca-MRSA strains characterised as ST75-MRSA-IV
and ST883-MRSA-IV have previously been shown to have MLST
alleles that are unique compared to other S. aureus genotypes (see
http://saureus.mlst.net/). In this study we have shown that the
array hybridisation patterns and the agr and rnpB gene sequences
for these two strains also differ from other S. aureus strains.
Furthermore, species-specific genes such as femA, coa, sbi or spa and
capsule genes were either absent or their sequences were
sufficiently divergent in the isolates studied to prevent their
detection by DNA array hybridisation. Whether these differences
justify the recognition of ST75 and ST883 as another species or as
distinct subspecies [3] is a matter of debate. Of practical
consequence is that nucleic acid based tests in general may not
yield a correct result because their performance depends on the
underlying sequence information. New variants or alleles of target
genes may not be detected if sequences of probe or primer binding
sites deviate from known sequences on which the design of the test
relied. Thus, our DNA array results may indicate that known
genome sequences do not reflect the whole biodiversity of S. aureus,
and consequently whole genome sequencing of divergent strains
such as ST75-MRSA-IV or ST883-MRSA-IV would be helpful.
While ST75-MRSA-IV are different from other S. aureus, the
isolates from this strain are rather homogenous. Variability
however was detected in the presence of seb gene and,
correspondingly, in the production of enterotoxin B. Only isolates,
in which seb was detected by primer-directed amplification were
shown to produce enterotoxin B. Complete or partial absence of
the seb gene or its replacement by a geno- and phenotypically
divergent variant are likely explanations for this observation. The
only other variations observed in ST75-MRSA-IV affected
possibly mobile resistance markers. Although ST883-MRSA-IV
lacks seb as well as the enterotoxin gene cluster egc and differs in
some MLST alleles (see http://saureus.mlst.net/), this strain
shares, in terms of hybridisation profile and rnpB gene sequences,
some features with ST75-MRSA-IV (see above and Supplemental
File S2).
The agr sequences of ST75 and ST883 are distinct from
previously known agr sequences. Furthermore, an 8% difference
between the agr sequences of these two strains was identified. For
comparison, a fragment of identical length from agr II sequences of
Mu50/N315 (CC5) and RF122 (CC151) differ by only 4%.
Based on DNA sequence, ST75/ST883 agr alleles could be
considered as representatives of a novel agr group although they
are less uniform than the other agr alleles. However, agr groups are
conventionally defined by phenotype rather than by genotype.
Although it was beyond the scope of this study to test ST75/
Figure 2. Phylogenetic network reconstruction based on DNA sequences of staphylococcal agr genes.
doi:10.1371/journal.pone.0014025.g002
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determine the amino acid sequence of the mature AIP from ST75
and ST883, predicted AIP amino acid sequences derived from
gene sequences were analysed. Predicted AIP amino acid sequence
differed for ST75 and ST883. ST75 yielded an agr group I AIP
amino acid sequence, while the AIP amino acid sequence of
ST883 was identical to agr group IV (Supplemental File S4). For
this reason, despite the differences demonstrated in the agr gene
sequences, these strains cannot be regarded as prototypic for a
novel agr group.
The agr alleles I to IV are distributed world-wide. The agr
groups I to III are known to include a variety of pandemic MRSA
and MSSA strains. The agr allele IV is less diverse, found only in a
few S aureus strains including ST50 and ST121 [9]. Although no
major MRSA strains belong to agr group IV, MSSA of ST121 are
known to be common and widespread in several countries [17–
20]. In contrast, strains with ST75/ST883-like agr alleles have only
been found in remote regions of northern Australia, where ST75-
MRSA-IV is frequently isolated [1]. Although no data on
methicillin-susceptible precursor strains are available, we assume
ST75- and ST883-MRSA strains originated in northern Australia,
and have evolved from pre-existent, local MSSA strains by
acquisition of SCCmec elements. While their genetic background
differs from other S. aureus strains, ST75- and ST883-MRSA
strains harbour SCCmec IV elements suggesting a recent
acquisition of these elements. Thus we assume that ST75/
ST883 may have evolved independently from other S. aureus
populations over an extended period of time and in recent years
has been transformed to MRSA by the global ‘‘infection-like’’
spread of SCCmec elements affecting several staphylococcal
species.
The genetic differences in ST75/ST883 may be due to a series
of evolutionary events in an ancient, insulated S. aureus strain. S.
aureus is a well adapted human parasite, which may have co-
evolved with humans resulting in a prehistoric radiation of S. aureus
into a number of divergent agr alleles. Much later, in the ages of
discovery and colonisation, a few S. aureus clonal lineages of
European, East Asian or African origin may have been spread
worldwide. For example, a recently published analysis of sequence
polymorphisms in ST5 (a global sequence type belonging to agr
group II) suggests a higher degree of diversity in Europe, and an
expansion approximately 1,000 years ago [21]. The agr-mediated
bacterial interference [8] could have been a driving force for an
evolution towards a very small number of competing allelic
variants (I to IV) resulting either in extinction of other agr alleles, or
in convergent evolution leading to similar AIP and agr gene
sequences. Evolution towards a certain uniformity might be a
stable strategy for competitors facing the same selective pressure,
as economists have noted already long ago [22]. Ancient, native S.
aureus strains may have been able to survive due to convergent
evolution or to recombination events resulting in the acquisition of
one of the four globally predominant agr alleles. We observed that
predicted AIP amino acid sequences of ST75 and ST883 are
identical to AIP sequences of agr group I and IV, respectively,
although their genetic background including the rest of their agr
sequences is different. This could indicate a convergent evolution
towards a limited number of main agr types. S aureus of ST93
(including another unique Australian caMRSA, the Queensland
Clone, ST93-MRSA-IV, [23]) may be another example. Its
overall genetic background also differs from the currently known
sequences resulting in a highly divergent hybridisation profile in
microarray experiments [2]. Although in this regard it resembles
ST75 and ST883, ST93 harbours an inconspicuous agr type III
locus [2;24].
In order to prove this concept of S. aureus evolution, historical
isolates and isolates from remote human communities and/or
native populations in different parts of the world should be
collected and scrutinised. This could provide an insight into the
evolution and biodiversity of an important human pathogen.
Materials and Methods
Strains and isolates
ST75-MRSA-IV: Eighteen isolates were collected between 2003
and 2008. Thirteen originated from the northern region of
Western Australia (03-17848, 04-15040, 04-15225, 04-15678, 04-
15778, 04-16031, 04-16785, 04-17342, 04-17542, 05-15398, 05-
15944, 06-16850, 08-18362), four from the Northern Territory
(03RDH76, 03RDH78, 03RDH93, 04RDH34) and one from
Queensland (06RBH23). Isolates were obtained from skin and soft
tissue infections or from screening cultures. All were genotyped by
DNA-array hybridisation. Phenotypic characterisation was per-
formed on five isolates (03-17848, 04-16031, 04-16785,
03RDH76, 06RBH23) using Vitek-2 and MALDI-TOF. Four
isolates (03-17848, 04-16785, 04-17542, 05-15398) were screened
for enterotoxin B production. One isolate (03-17848) was selected
for further characterisation and sequencing.
ST883-MRSA-IV: A single isolate (06-16607) was characterised
which was obtained from a hand swab collected in 2006 in the
northern region of Western Australia.
No patient data were stored or used for this study; thus formal
ethics committee approval and informed consent from the patients
were not required.
Control strains: Fully sequenced strains MSSA476 (ST1-
MSSA), MW2-USA400 (ST1-MRSA-IV), Mu50 (ST5-MRSA-
II), N315 (ST5-MRSA-II), NCTC 8325 (ST8-MSSA), COL
(ST250-MRSA-I), USA300-FPR3757 (ST8-MRSA-IV), and San-
ger MRSA 252 (CC30-MRSA-II) were included for comparison.
Phenotypic characterisation
Culture morphology was assessed on Columbia blood agar. The
clumping factor test was performed using a commercial assay
(Pastorex Staph-Plus, Bio-Rad, Munich, Germany). Standard
biochemistry was determined by the Vitek 2 Gram Positive
Identification card (BioMerieux, Nuertingen, Germany). MALDI-
TOF analysis was performed using the MALDI Biotyper (Bruker,
Bremen, Germany) according to manufacturer’s specifications.
Pulsed field gel electrophoresis, spa-, MLST and SCCmec-
typing
Pulsed field gel electrophoresis, spa-, and MLST typing
procedures were performed according to previously published
protocols [25–27]. SCCmec-typing procedures were performed as
described previously [28].
Array procedures
The DNA array (StaphyType system by Alere Technologies
GmbH, Jena, Germany) used in this study included probes for 334
different target sequences which corresponds to, depending on the
nomenclature used, approximately 180 distinct genes and their
different alleles. This included species controls, typing markers (agr,
capsule and SCCmec-related genes), genes encoding exotoxins or
MSCRAMMs as well as resistance markers.
After overnight incubation on Columbia blood agar, colonies
were harvested and lysed using lysostaphin, lysozyme and
ribonuclease A followed by digestion with proteinase K. The
DNA was purified using the QIAGEN device EZ1 (QIAGEN,
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protocol.
Two different protocols were used for linear amplification and
biotin labelling of amplicons. The first, a target sequence-
dependent, primer-directed amplification protocol, [2;24;29;30]
is a thermally synchronised iterated linear primer elongation
method in which a mixture of antisense primers for all targets
facilitated a simultaneous copying of all target sequences to single
stranded DNA. Within this step, amplicons are labelled by
incorporation of biotin-16-dUTP.
The second protocol is a target sequence-independent random
amplification procedure [31–34] resulting in biotin labelled
amplicons representing the complete input genome sequence.
This method detects target genes for which the binding sites of the
primers used in the first protocol were deleted or changed by
nucleotide polymorphisms. Thus, this method is more suited to
characterise strains for which sequence data are not available yet.
Primers were used which consisted of a random sequence and of
an invariant part. The latter was used as a primer binding site for a
second round of amplification. Amplicons were also labelled by
incorporation of biotin-16-dUTP.
Post amplification, the labelled samples were denatured and
hybridised to the array. This was followed by several washing steps
and the addition of a blocking reagent. Horseradish-peroxidase-
streptavidin conjugate was added to the array, followed by
incubation and washing. A precipitating dye (Seramun Green,
Seramun, Heidesee, Germany) was then added, and the
hybridisation pattern was analysed using a designated reading
device and software (ArrayMate by Alere Technologies GmbH).
Sequence analysis of 16S rRNA genes
16S rRNA genes were amplified using Sa16S-F (59-TTT TAT
GGA GAG TTT GAT CC-39) and Sa16S-R (59-AGA AAG GAG
GTG ATC CAG-39) primers. The resulting PCR products
(1,555 bp) were purified and sequenced with amplification primers
and Sa16S-1-4 primers (Table 1). 20 ng of purified DNA and the
BigDye Terminator v1.1 Cycle Sequencing Kit (Applied Biosys-
tems) were used in cycle sequencing according to manufacturer’s
instructions.
Sequence analysis of rnpB
The rnpB locus was amplified using genomic DNA and rnpB-fw-
01 (59- AGTTTAACTGTCTTACTAATAATGACT-39) and
rnpB-rev-02 (59- ACAAGGCAGTGTCATTATATCA-39) prim-
ers. The resulting PCR products (528 bp) were subcloned using
the TOPO TA Cloning Kit (Invitrogen, Darmstadt, Germany).
Sequencing of purified plasmid DNA was carried out as a cycle
sequencing procedure using the BigDye Terminator v1.1 Cycle
Sequencing Kit (Applied Biosystems). Briefly, 200 ng of plasmid
DNA, M13 reverse primer (59-CAG GAA ACA GCT ATG AC-
39) and M13 (-21) primer (59-GTA AAA CGA CGG CCA GT-39)
were used in this process. Sequencing products were analysed on
an ABI Prism 310 Genetic Analyzer (Applied Biosystems).
Sequence analysis of the agr locus
Primers used for the sequencing of the ST75 and ST883 agr
allele are listed in Table 1. Primers agrC_uni_fw, agrA_uni_rv,
agrB_uni_fw and agrC_uni_rv were derived from conserved loci
of known agr alleles. Primers were also derived from sequences
obtained by the use of agrC_uni_fw, agrA_uni_rv, agrB_uni_fw
and agrC_uni_rv primers. DNA sequencing was performed using
either PCR products obtained with agrA_uni_rv and agrB_uni_fw
primers or purified plasmid DNA resulting from cloning these
PCR products. This was performed as a cycle sequencing
procedure using BigDye Terminator v1.1 Cycle Sequencing Kit
(Applied Biosystems, Darmstadt, Germany) according to the
manufacturer’s recommendations as well as DNA sequencers
ABI Prism 377 or 3100 (Perkin-Elmer/Applied Biosystems, Foster
City, CA).
Enterotoxin B detection
Protein arrays using enterotoxin B specific capture and
detection antibodies were used to test four ST75-MRSA-IV
isolates and the ST883-MRSA-IV-isolate for the production of
enterotoxin B. Culture supernatants (overnight incubation, liquid
medium as described by Kato and Noda [35]) were used for
testing in a 1:10 dilution. Details on technology and protocols have
been described previously [36].
Phylogenetic tree reconstruction
For phylogenetic tree reconstruction, SplitsTree software [37]
was used with default settings (characters transformation, uncor-
rected P; distance transformation, Neighbour-Net; and variance,
ordinary least squares).
For Figure 1, staphylococcal rnpB genes wereanalysed. Besidethe
ST75 and ST883 sequences obtained in this study, the following
GenBank entries were used: ‘‘other S. aureus’’, i.e., MSSA476,
BX571857.1; MW2, BA000033.2; Mu50, BA000017.4; N315,
BA000018.3; COL, CP000046.1; NCTC8325, CP000253.1;
USA300-FPR3757, CP000255 and MRSA252, BX571856.1 as
well as S. epidermidis RP62A, CP000029.1 and SR1, AF270230.1; S.
haemolyticus JCSC1435, AP006716.1; S. lugdunensis HKU09-01,
CP001837.1; S. saprophyticus ATCC15305, AP008934.1.
For Figure 2, staphylococcal agr genes were analysed. Beside the
ST75 and ST883 sequences from this study, the following GenBank
entries were used: MSSA476, BX571857.1; MW2, BA000033.2;
Mu50, BA000017.4; N315, BA000018.3; COL, CP000046.1;
NCTC8325, CP000253.1; USA300-FPR3757, CP000255; H560,
DQ157981.1; RN4850, DQ229853.1; RF122, AJ938182.1;
UK9810618, DQ157966 and MRSA252, BX571856.1; S. arlettae
DSM20672, AF346712.1; S. cohnii ATCC49330, AF346721.1; S.
epidermidisA086,Z49220.1aswellasRP62A,CP000029.1andSR1,
AF270230.1; S. gallinarum CCM3572, AF346722.; S. haemolyticus
JCSC1435, AP006716.1; S. intermedius S3, AY965912.1; S. lugdu-
nensis 307, AF173933.1; S. saprophyticus ATCC15305, AP008934.1
and AJ639613.1 as well as S. xylosus ATCC29971, AF346729.1.
Supporting Information
File S1 This file shows the Vitek 2 biochemical profile of the
study strains in comparison to a reference strain.
Found at: doi:10.1371/journal.pone.0014025.s001 (0.01 MB
PDF)
File S2 This files shows array hybridisation results of ST75-
MRSA-IV and ST883-MRSA-IV as well as of some reference
strains for comparison.
Found at: doi:10.1371/journal.pone.0014025.s002 (1.19 MB
PDF)
File S3 This files shows the detection of enterotoxin B in studied
strains and reference strains.
Found at: doi:10.1371/journal.pone.0014025.s003 (2.78 MB
PDF)
File S4 This file shows that, despite of unique agr gene
sequences, predicted autoinducing peptide sequences of ST75
and ST883 allow them to be assigned to agr groups I and IV,
respectively.
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